| Year |
Citation |
Score |
| 2010 |
Peleg S, Nguyen CV. The importance of nuclear import in protection of the vitamin D receptor from polyubiquitination and proteasome-mediated degradation. Journal of Cellular Biochemistry. 110: 926-34. PMID 20564192 DOI: 10.1002/jcb.22606 |
0.65 |
|
| 2010 |
Peleg S, Sellin JH, Wang Y, Freeman MR, Umar S. Suppression of aberrant transient receptor potential cation channel, subfamily V, member 6 expression in hyperproliferative colonic crypts by dietary calcium. American Journal of Physiology. Gastrointestinal and Liver Physiology. 299: G593-601. PMID 20508153 DOI: 10.1152/ajpgi.00193.2010 |
0.402 |
|
| 2007 |
Petersen KS, Dolan PM, Kensler TW, Peleg S, Posner GH. Low-calcemic, highly antiproliferative, 23-oxa ether analogs of the natural hormone 1α,25-dihydroxyvitamin D3: Design, synthesis, and preliminary biological evaluation Journal of Medicinal Chemistry. 50: 5824-5832. PMID 17924616 DOI: 10.1021/Jm070882D |
0.455 |
|
| 2007 |
Peleg S. Responsiveness of osteoblastic and osteolytic bone metastases to vitamin D analogs. Critical Reviews in Eukaryotic Gene Expression. 17: 149-58. PMID 17725485 DOI: 10.1615/critreveukargeneexpr.v17.i2.40 |
0.355 |
|
| 2007 |
Kittaka A, Saito N, Honzawa S, Takenouchi K, Ishizuka S, Chen TC, Peleg S, Kato S, Arai MA. Creative synthesis of novel vitamin D analogs for health and disease. The Journal of Steroid Biochemistry and Molecular Biology. 103: 269-76. PMID 17223554 DOI: 10.1016/j.jsbmb.2006.12.002 |
0.518 |
|
| 2007 |
Posner GH, Suh BC, Petersen KS, Dolan P, Agoston ES, Kensler TW, Koh JT, Peleg S. Difluoromethyl analogs of the natural hormone 1α,25-dihydroxyvitamin D3: Design, synthesis, and preliminary biological evaluation Journal of Steroid Biochemistry and Molecular Biology. 103: 213-221. PMID 17218093 DOI: 10.1016/J.Jsbmb.2006.12.024 |
0.474 |
|
| 2007 |
Klopot A, Hance KW, Peleg S, Barsony J, Fleet JC. Nucleo-cytoplasmic cycling of the vitamin D receptor in the enterocyte-like cell line, Caco-2. Journal of Cellular Biochemistry. 100: 617-28. PMID 16960876 DOI: 10.1002/jcb.21087 |
0.748 |
|
| 2006 |
Peleg S, Petersen KS, Suh BC, Dolan P, Agoston ES, Kensler TW, Posner GH. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1α,25-dihydroxyvitamin D3: Design, synthesis, and preliminary biological evaluation Journal of Medicinal Chemistry. 49: 7513-7517. PMID 17149880 DOI: 10.1021/Jm0609925 |
0.341 |
|
| 2005 |
Peleg S, Khan F, Navone NM, Cody DD, Johnson EM, Van Pelt CS, Posner GH. Inhibition of prostate cancer-meditated osteoblastic bone lesions by the low-calcemic analog 1alpha-hydroxymethyl-16-ene-26,27-bishomo-25-hydroxy vitamin D3. The Journal of Steroid Biochemistry and Molecular Biology. 97: 203-11. PMID 16081281 DOI: 10.1016/J.Jsbmb.2005.06.015 |
0.35 |
|
| 2005 |
Phokela SS, Peleg S, Moya FR, Alcorn JL. Regulation of human pulmonary surfactant protein gene expression by 1alpha,25-dihydroxyvitamin D3. American Journal of Physiology. Lung Cellular and Molecular Physiology. 289: L617-26. PMID 15951333 DOI: 10.1152/ajplung.00129.2004 |
0.457 |
|
| 2005 |
Posner GH, Lee SHT, Kim HJ, Peleg S, Dolan P, Kensler TW. Novel A-ring analogs of the hormone 1α,25-dihydroxyvitamin D 3: Synthesis and preliminary biological evaluation Bioorganic and Medicinal Chemistry. 13: 2959-2966. PMID 15781405 DOI: 10.1016/J.Bmc.2005.02.005 |
0.375 |
|
| 2004 |
Swamy N, Chen TC, Peleg S, Dhawan P, Christakos S, Stewart LV, Weigel NL, Mehta RG, Holick MF, Ray R. Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 8018-27. PMID 15585637 DOI: 10.1158/1078-0432.Ccr-04-0881 |
0.674 |
|
| 2004 |
Malloy PJ, Xu R, Peng L, Peleg S, Al-Ashwal A, Feldman D. Hereditary 1,25-dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function. Endocrinology. 145: 5106-14. PMID 15308610 DOI: 10.1210/en.2004-0080 |
0.604 |
|
| 2004 |
Posner GH, Crawford KR, Yang HW, Kahraman M, Jeon HB, Li H, Lee JK, Suh BC, Hatcher MA, Labonte T, Usera A, Dolan PM, Kensler TW, Peleg S, Jones G, et al. Potent, low-calcemic, selective inhibitors of CYP24 hydroxylase: 24-Sulfone analogs of the hormone 1α,25-dihydroxyvitamin D3 Journal of Steroid Biochemistry and Molecular Biology. 89: 5-12. PMID 15225738 DOI: 10.1016/J.Jsbmb.2004.03.044 |
0.357 |
|
| 2004 |
Ismail A, Nguyen CV, Ahene A, Fleet JC, Uskokovic MR, Peleg S. Effect of cellular environment on the selective activation of the vitamin D receptor by 1alpha,25-dihydroxyvitamin D3 and its analog 1alpha-fluoro-16-ene-20-epi-23-ene-26,27-bishomo-25-hydroxyvitamin D3 (Ro-26-9228). Molecular Endocrinology (Baltimore, Md.). 18: 874-87. PMID 14726489 DOI: 10.1210/me.2003-0310 |
0.496 |
|
| 2003 |
Peleg S, Posner GH. Vitamin D analogs as modulators of vitamin D receptor action. Current Topics in Medicinal Chemistry. 3: 1555-1572. PMID 14683515 DOI: 10.2174/1568026033451691 |
0.666 |
|
| 2003 |
Kittaka A, Kurihara M, Peleg S, Suhara Y, Takayama H. 2 alpha-(3-hydroxypropyl)- and 2 alpha-(3-hydroxypropoxy)-1 alpha,25-dihydroxyvitamin D3 accessible to vitamin D receptor mutant related to hereditary vitamin D-resistant rickets. Chemical & Pharmaceutical Bulletin. 51: 357-8. PMID 12612432 DOI: 10.1248/cpb.51.357 |
0.478 |
|
| 2003 |
Peleg S, Ismail A, Uskokovic MR, Avnur Z. Evidence for tissue- and cell-type selective activation of the vitamin D receptor by Ro-26-9228, a noncalcemic analog of vitamin D3. Journal of Cellular Biochemistry. 88: 267-73. PMID 12520525 DOI: 10.1002/jcb.10344 |
0.495 |
|
| 2002 |
Rehan VK, Torday JS, Peleg S, Gennaro L, Vouros P, Padbury J, Rao DS, Reddy GS. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells. Molecular Genetics and Metabolism. 76: 46-56. PMID 12175780 DOI: 10.1016/S1096-7192(02)00022-7 |
0.529 |
|
| 2002 |
Peleg S, Uskokovic M, Ahene A, Vickery B, Avnur Z. Cellular and molecular events associated with the bone-protecting activity of the noncalcemic vitamin D analog Ro-26-9228 in osteopenic rats. Endocrinology. 143: 1625-36. PMID 11956143 DOI: 10.1210/endo.143.5.8777 |
0.526 |
|
| Show low-probability matches. |